Vidyya Medical News Servicesm
Vidyya, from the Sanskrit "vaidya," a practitioner who has come to understand the science of life.
 |
Vidyya |
|
Ars Medica Home |
|
Vidyya Archives |
|
Search Vidyya |
|
Ex Libris |
|
Subscriptions |
|
About Vidyya |
|
|
|
NCI Announces Clinical Trials Gateway Web Feature A fundamental change is under way in how the National Cancer Institute (NCI) develops, reviews, conducts, and supports clinical trials. The revitalized system is more flexible and more inclusive, inviting input from basic and clinical researchers, community and research oncologists, patients and families, and every group with a commitment to improving cancer care. More... |
|
New England Journal Of Medicine Early Release E coli causes sporadic and epidemic gastrointestinal infections worldwide. In 15% of the children who are infected with E. coli, the hemolytic-uremic syndrome develops. Treatment with antibiotics does not ameliorate E. coli O157:H7 infections, and has been associated with worse clinical outcomes. New results confirm that sulfa-containing antibiotics increase the risk of the hemolytic-uremic syndrome and indicate that (beta)-lactam antibiotics are associated with a similar degree of risk. More.... |
|
SU 5416, Anti-VEGF And IMC-C225: Drugs To Watch Drugs that stangle, cut-off, choke, inhibit or stop the blood supply to neoplastic growths have been attracting attention at the American Society of Clinical Oncologists meetings this week. Read Drugs To Watch. |
|
Clamping Down On Medical Research The news has been filled with talk of improper, even fraudulent behavior during clinical trials. From improper report filing during Rezulin clinical trials to fraud during breast cancer chemotherapy trials, the clinical trial system appears to be in disarray. In response, the Clinton administration announced steps to improve patient safety during clinical trials. More... |
Ars Medica Home | Ex Libris | Vidyya |
Subscription Information | About Vidyya | Vidyya Archives |
Editor: Susan K. Boyer, RN
© RAmEx Ars Medica, Inc. All rights reserved.